Blocking type i interferon production: A new therapeutic option to reduce the HIV-1-induced immune activation

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Ries, Moritz ^a   Pritschet, Kathrin ^a   Schmidt, Barbara ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTERFERON;

ACIDIFICATION; ANUS CANCER; CD4 LYMPHOCYTE COUNT; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOSOME; EPSTEIN BARR VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOTHERAPY; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION; WART VIRUS; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; TRANSLATIONAL RESEARCH;

ANIMALS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ENDOSOMES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOMODULATION; INTERFERON TYPE I; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84855611213     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/534929     Document Type: Review

References (93)

1. De Clercq E., Antiretroviral drugs Current Opinion in Pharmacology 2010 10 5 507 515
2. Hawkins T., Understanding and managing the adverse effects of antiretroviral therapy Antiviral Research 2010 85 1 201 209
3. Deeks S. G., HIV infection, inflammation, immunosenescence, and aging Annual Review of Medicine 2011 62 141 155
4. Palefsky J., Human papillomavirus and anal neoplasia Current HIV/AIDS Reports 2008 5 2 87 85
5. Fitzgerald-Bocarsly P., Jacobs E. S., Plasmacytoid dendritic cells in HIV infection: striking a delicate balance Journal of Leukocyte Biology 2010 87 4 609 620
6. Herbeuval J. P., Shearer G. M., HIV-1 immunopathogenesis: how good interferon turns bad Clinical Immunology 2007 123 2 121 128 (Pubitemid 46590066)
7. Kirchhoff F., Is the high virulence of HIV-1 an unfortunate coincidence of primate lentiviral evolution? Nature Reviews Microbiology 2009 7 6 467 476
8. Popovic M., Tenner-Racz K., Pelser C., Stellbrink H. J., Van Lunzen J., Lewis G., Kalyanaraman V. S., Gallo R. C., Racz P., Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy Proceedings of the National Academy of Sciences of the United States of America 2005 102 41 14807 14812 (Pubitemid 41457137)
9. Giorgi J. V., Hultin L. E., McKeating J. A., Johnson T. D., Owens B., Jacobson L. P., Shih R., Lewis J., Wiley D. J., Phair J. P., Wolinsky S. M., Detels R., Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage Journal of Infectious Diseases 1999 179 4 859 870 (Pubitemid 29159331)
10. Hazenberg M. D., Stuart J. W. T., Otto S. A., Borleffs J. C. C., Boucher C. A. B., De Boer R. J., Miedema F., Hamann D., T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART) Blood 2000 95 1 249 255 (Pubitemid 30017249)
11. Liu Z., Cumberland W. G., Hultin L. E., Prince H. E., Detels R., Giorgi J. V., Elevated CD38 antigen expression on CD8 + T cells Is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the multicenter AIDS Cohort study than CD4 + cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1997 16 2 83 92
12. Sousa A. E., Carneiro J., Meier-Schellersheim M., Grossman Z., Victorino R. M. M., CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load Journal of Immunology 2002 169 6 3400 3406 (Pubitemid 35013190)
13. Valdez H., Lederman M. M., Cytokines and cytokine therapies in HIV infection AIDS Clinical Review 1997 187 228
14. Pandrea I., Sodora D. L., Silvestri G., Apetrei C., Into the wild: simian immunodeficiency virus (SIV) infection in natural hosts Trends in Immunology 2008 29 9 419 428
15. Silvestri G., Paiardini M., Pandrea I., Lederman M. M., Sodora D. L., Understanding the benign nature of SIV infection in natural hosts Journal of Clinical Investigation 2007 117 11 3148 3154 (Pubitemid 350096967)
16. Kneitz C., Kerkau T., Muller J., Coulibaly C., Stahl-Hennig C., Hunsmann G., Hunig T., Schimpl A., Early phenotypic and functional alterations in lymphocytes from simian immunodeficiency virus infected macaques Veterinary Immunology and Immunopathology 1993 36 3 239 255
17. Brenchley J. M., Schacker T. W., Ruff L. E., Price D. A., Taylor J. H., Beilman G. J., Nguyen P. L., Khoruts A., Larson M., Haase A. T., Douek D. C., CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract Journal of Experimental Medicine 2004 200 6 749 759 (Pubitemid 39299461)
18. Guadalupe M., Reay E., Sankaran S., Prindiville T., Flamm J., McNeil A., Dandekar S., Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy Journal of Virology 2003 77 21 11708 11717 (Pubitemid 37271669)
19. Mattapallil J. J., Douek D. C., Hill B., Nishimura Y., Martin M., Roederer M., Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection Nature 2005 434 7037 1093 1097 (Pubitemid 40663481)
20. Mehandru S., Poles M. A., Tenner-Racz K., Horowitz A., Hurley A., Hogan C., Boden D., Racz P., Markowitz M., Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract Journal of Experimental Medicine 2004 200 6 761 770 (Pubitemid 39299462)
21. Picker L. J., Hagen S. I., Lum R., Reed-Inderbitzin E. F., Daly L. M., Sylwester A. W., Walker J. M., Siess D. C., Piatak M., Wang C., Allison D. B., Maino V. C., Lifson J. D., Kodama T., Axthelm M. K., Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection Journal of Experimental Medicine 2004 200 10 1299 1314 (Pubitemid 39552571)
22. Veazey R. S., DeMaria M., Chalifoux L. V., Shvetz D. E., Pauley D. R., Knight H. L., Rosenzweig M., Johnson R. P., Desrosiers R. C., Lackner A. A., Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection Science 1998 280 5362 427 431 (Pubitemid 28208163)
23. Brenchley J. M., Price D. A., Schacker T. W., Asher T. E., Silvestri G., Rao S., Kazzaz Z., Bornstein E., Lambotte O., Altmann D., Blazar B. R., Rodriguez B., Teixeira-Johnson L., Landay A., Martin J. N., Hecht F. M., Picker L. J., Lederman M. M., Deeks S. G., Douek D. C., Microbial translocation is a cause of systemic immune activation in chronic HIV infection Nature Medicine 2006 12 12 1365 1371 (Pubitemid 44924494)
24. Leinert C., Stahl-Hennig C., Ecker A., Schneider T., Fuchs D., Sauermann U., Sopper S., Microbial translocation in simian immunodeficiency virus (SIV)-infected rhesus monkeys (Macaca mulatta) Journal of Medical Primatology 2010 39 4 243 251
25. Isaacs A., Lindenmann J., Virus interference. I. The interferon. By A. Isaacs and J. Lindenmann, 1957 Journal of Interferon Research 1987 7 5 429 438
26. Pestka S., Krause C. D., Walter M. R., Interferons, interferon-like cytokines, and their receptors Immunological Reviews 2004 202 8 32 (Pubitemid 39576902)
27. Cella M., Jarrossay D., Faccheth F., Alebardi O., Nakajima H., Lanzavecchia A., Colonna M., Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon Nature Medicine 1999 5 8 919 923 (Pubitemid 29372419)
28. Siegal F. P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P. A., Shah K., Ho S., Antonenko S., Liu Y. J., The nature of the principal Type 1 interferon-producing cells in human blood Science 1999 284 5421 1835 1837
29. Fitzgerald-Bocarsly P., Feng D., The role of type I interferon production by dendritic cells in host defense Biochimie 2007 89 6-7 843 855 (Pubitemid 47001647)
30. Kadowaki N., Ho S., Antonenko S., De Waal Malefyt R., Kastelein R. A., Bazan F., Liu Y. J., Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens Journal of Experimental Medicine 2001 194 6 863 869 (Pubitemid 32983021)
31. Cella M., Facchetti F., Lanzavecchia A., Colonna M., Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization Nature Immunology 2000 1 4 305 310
32. Kadowaki N., Antonenko S., Lau J. Y. N., Liu Y. J., Natural interferon / -producing cells link innate and adaptive immunity Journal of Experimental Medicine 2000 192 2 219 225 (Pubitemid 30470304)
33. Beignon A. S., McKenna K., Skoberne M., Manches O., DaSilva I., Kavanagh D. G., Larsson M., Gorelick R. J., Lifson J. D., Bhardwaj N., Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions Journal of Clinical Investigation 2005 115 11 3265 3275 (Pubitemid 41567591)
34. Fong L., Mengozzi M., Abbey N. W., Herndier B. G., Engleman E. G., Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation Journal of Virology 2002 76 21 11033 11041 (Pubitemid 35176220)
35. Fonteneau J. F., Larsson M., Beignon A. S., McKenna K., Dasilva I., Amara A., Liu Y. J., Lifson J. D., Littman D. R., Bhardwaj N., Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells Journal of Virology 2004 78 10 5223 5232 (Pubitemid 38581474)
36. Herbeuval J. P., Hardy A. W., Boasso A., Anderson S. A., Dolan M. J., Dy M., Shearer G. M., Regulation of TNF-related apoptosis-inducing ligand on primary CD4 + T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells Proceedings of the National Academy of Sciences of the United States of America 2005 102 39 13974 13979 (Pubitemid 41377688)
37. Herbeuval J. P., Grivel J. C., Boasso A., Hardy A. W., Chougnet C., Dolan M. J., Yagita H., Lifson J. D., Shearer G. M., CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis Blood 2005 106 10 3524 3531 (Pubitemid 41609189)
38. Yonezawa A., Morita R., Takaori-Kondo A., Kadowaki N., Kitawaki T., Hori T., Uchiyama T., Natural alpha interferon-producing cells respond to human immunodeficiency virus type 1 with alpha interferon production and maturation into dendritic cells Journal of Virology 2003 77 6 3777 3784 (Pubitemid 36297296)
39. Lepelley A., Louis S., Sourisseau M., Law H. K.W., Pothlichet J., Schilte C., Chaperot L., Plumas J., Randall R. E., Si-Tahar M., Mammano F., Albert M. L., Schwartz O., Innate sensing of HIV-infected cells PLoS Pathogens 2011 7 2, article e1001284
40. Schmidt B., Ashlock B. M., Foster H., Fujimura S. H., Levy J. A., HIV-infected cells are major inducers of plasmacytoid dendritic cell interferon production, maturation, and migration Virology 2005 343 2 256 266 (Pubitemid 41598365)
41. Haupt S., Donhauser N., Chaipan C., Schuster P., Puffer B., Daniels R. S., Greenough T. C., Kirchhoff F., Schmidt B., CD4 binding affinity determines human immunodeficiency virus type 1-induced alpha interferon production in plasmacytoid dendritic cells Journal of Virology 2008 82 17 8900 8905
42. Martinelli E., Cicala C., Van Ryk D., Goode D. J., Macleod K., Arthos J., Fauci A. S., HIV-1 gp120 inhibits TLR9-mediated activation and IFN- secretion in plasmacytoid dendritic cells Proceedings of the National Academy of Sciences of the United States of America 2007 104 9 3396 3401 (Pubitemid 46364170)
43. Milone M. C., Fitzgerald-Bocarsly P., The mannose receptor mediates induction of IFN- in peripheral blood dendritic cells by enveloped RNA and DNA viruses Journal of Immunology 1998 161 5 2391 2399 (Pubitemid 28397053)
44. Schmidt B., Scott I., Whitmore R. G., Foster H., Fujimura S., Schmitz J., Levy J. A., Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation Virology 2004 329 2 280 288 (Pubitemid 39423978)
45. Cameron P. U., Handley A. J., Baylis D. C., Solomon A. E., Bernard N., Purcell D. F. J., Lewin S. R., Preferential infection of dendritic cells during human immunodeficiency virus type 1 infection of blood leukocytes Journal of Virology 2007 81 5 2297 2306
46. Evans V. A., Lal L., Akkina R., Solomon A., Wright E., Lewin S. R., Cameron P. U., Thymic plasmacytoid dendritic cells are susceptible to productive HIV-1 infection and efficiently transfer R5 HIV-1 to thymocytes in vitro Retrovirology 2011 8, article 43
47. Smed-Srensen A., Loré K., Vasudevan J., Louder M. K., Andersson J., Mascola J. R., Spetz A. L., Koup R. A., Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells Journal of Virology 2005 79 14 8861 8869 (Pubitemid 40934796)
48. Hardy A. W., Graham D. R., Shearer G. M., Herbeuval J. P., HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN- Proceedings of the National Academy of Sciences of the United States of America 2007 104 44 17453 17458 (Pubitemid 350219859)
49. O'Brien M., Manches O., Sabado R. L., Baranda S. J., Wang Y., Marie I., Rolnitzky L., Markowitz M., Margolis D. M., Levy D., Bhardwaj N., Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN- -producing and partially matured phenotype Journal of Clinical Investigation 2011 121 3 1088 1101
50. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S., Species-Specific Recognition of Single-Stranded RNA via Till-like Receptor 7 and 8 Science 2004 303 5663 1526 1529 (Pubitemid 38314424)
51. Mandl J. N., Barry A. P., Vanderford T. H., Kozyr N., Chavan R., Klucking S., Barrat F. J., Coffman R. L., Staprans S. I., Feinberg M. B., Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections Nature Medicine 2008 14 10 1077 1087
52. Pitha P. M., Multiple effects of interferon on the replication of human immunodeficiency virus type 1 Antiviral Research 1994 24 2-3 205 219 (Pubitemid 24228875)
53. Yamamoto J. K., Barre-Sinoussi F., Bolton V., Pedersen N. C., Gardner M. B., Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2 Journal of Interferon Research 1986 6 2 143 152 (Pubitemid 16098762)
54. Altfeld M., Fadda L., Frleta D., Bhardwaj N., DCs and NK cells: critical effectors in the immune response to HIV-1 Nature Reviews Immunology 2011 11 3 176 186
55. Herbeuval J. P., Nilsson J., Boasso A., Hardy A. W., Kruhlak M. J., Anderson S. A., Dolan M. J., Dy M., Andersson J., Shearer G. M., Differential expression of IFN- and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients Proceedings of the National Academy of Sciences of the United States of America 2006 103 18 7000 7005
56. Boasso A., Herbeuval J. P., Hardy A. W., Anderson S. A., Dolan M. J., Fuchs D., Shearer G. M., HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells Blood 2007 109 8 3351 3359 (Pubitemid 46572523)
57. Boasso A., Hardy A. W., Anderson S. A., Dolan M. J., Shearer G. M., HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation PLoS ONE 2008 3 8
58. Manches O., Munn D., Fallahi A., Lifson J., Chaperot L., Plumas J., Bhardwaj N., HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism Journal of Clinical Investigation 2008 118 10 3431 3439
59. Meyers J. H., Justement J. S., Hallahan C. W., Blair E. T., Sun Y. A., O'Shea M. A., Roby G., Kottilil S., Moir S., Kovacs C. M., Chun T. W., Fauci A. S., Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cells PLoS ONE 2007 2 5, article e458
60. Tilton J. C., Manion M. M., Luskin M. R., Johnson A. J., Patamawenu A. A., Hallahan C. W., Cogliano-Shutta N. A., Mican J. M., Davey R. T., Kottilil S., Lifson J. D., Metcalf J. A., Lempicki R. A., Connors M., Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro Journal of Virology 2008 82 8 3997 4006 (Pubitemid 351521235)
61. Meythaler M., Martinot A., Wang Z., Pryputniewicz S., Kasheta M., Ling B., Marx P. A., O'Neil S., Kaur A., Differential CD4+ T-lymphocyte apoptosis and bystander T-cell activation in rhesus macaques and sooty mangabeys during acute simian immunodeficiency virus infection Journal of Virology 2009 83 2 572 583
62. Bosinger S. E., Li Q., Gordon S. N., Klatt N. R., Duan L., Xu L., Francella N., Sidahmed A., Smith A. J., Cramer E. M., Zeng M., Masopust D., Carlis J. V., Ran L., Vanderford T. H., Paiardini M., Isett R. B., Baldwin D. A., Else J. G., Staprans S. I., Silvestri G., Haase A. T., Kelvin D. J., Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys Journal of Clinical Investigation 2009 119 12 3556 3572
63. Diop O. M., Ploquin M. J. Y., Mortara L., Faye A., Jacquelin B., Kunkel D., Lebon P., Butor C., Hosmalin A., Barré-Sinoussi F., Mller-Trutwin M. C., Plasmacytoid dendritic cell dynamics and alpha interferon production during simian immunodeficiency virus infection with a nonpathogenic outcome Journal of Virology 2008 82 11 5145 5152 (Pubitemid 351705223)
64. Harris L. D., Tabb B., Sodora D. L., Paiardini M., Klatt N. R., Douek D. C., Silvestri G., Mller-Trutwin M., Vasile-Pandrea I., Apetrei C., Hirsch V., Lifson J., Brenchley J. M., Estes J. D., Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques Journal of Virology 2010 84 15 7886 7891
65. Jacquelin B., Mayau V., Targat B., Liovat A. S., Kunkel D., Petitjean G., Dillies M. A., Roques P., Butor C., Silvestri G., Giavedoni L. D., Lebon P., Barré-Sinoussi F., Benecke A., Mller-Trutwin M. C., Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response Journal of Clinical Investigation 2009 119 12 3544 3555
66. Abb J., Zachoval R., Zachoval V., Deinhardt F., HIV antigen, HIV antibody and serum interferon in a patient with encephalopathy Infection 1987 15 6 425 426 (Pubitemid 18082257)
67. Minagawa T., Mizuno K., Hirano S., Asano M., Numata A., Kohanawa M., Nakane A., Hachimori K., Tamagawa S., Negishi M., Yamazaki S., Satoh Y. I., AIDS research communications: detection of high levels of immunoreactive human beta-1 interferon in sera from HIV-infected patients Life Sciences 1989 45 11 iii vii
68. von Sydow M., Sonnerborg A., Gaines H., Strannegard O., Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection AIDS Research and Human Retroviruses 1991 7 4 375 380
69. Chehimi J., Papasavvas E., Tomescu C., Gekonge B., Abdulhaqq S., Raymond A., Hancock A., Vinekar K., Carty C., Reynolds G., Pistilli M., Mounzer K., Kostman J., Montaner L. J., Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand Journal of Virology 2010 84 6 2762 2773
70. Sherer N. M., Lehmann M. J., Jimenez-Soto L. F., Horensavitz C., Pypaert M., Mothes W., Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission Nature Cell Biology 2007 9 3 310 315 (Pubitemid 46344610)
71. Sattentau Q., Avoiding the void: cell-to-cell spread of human viruses Nature Reviews Microbiology 2008 6 11 815 826
72. Nascimbeni M., Perié L., Chorro L., Diocou S., Kreitmann L., Louis S., Garderet L., Fabiani B., Berger A., Schmitz J., Marie J. P., Molina T. J., Pacanowski J., Viard J. P., Oksenhendler E., Beq S., Abehsira-Amar O., Cheynier R., Hosmalin A., Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon- expression Blood 2009 113 24 6112 6119
73. Kwa S., Kannanganat S., Nigam P., Siddiqui M., Shetty R. D., Armstrong W., Ansari A., Bosinger S. E., Silvestri G., Amara R. R., Plasmacytoid dendritic cells are recruited to the colorectum and contribute to immune activation during pathogenic SIV infection in rhesus macaques Blood 2011 118 10 2763 2773
74. Chehimi J., Campbell D. E., Azzoni L., Bacheller D., Papasavvas E., Jerandi G., Mounzer K., Kostman J., Trinchieri G., Montaner L. J., Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals Journal of Immunology 2002 168 9 4796 4801 (Pubitemid 34441389)
75. Donhauser N., Helm M., Pritschet K., Schuster P., Ries M., Korn K., Vollmer J., Schmidt B., Differential effects of P-class versus other CPG oligodeoxynucleotide classes on the impaired innate immunity of plasmacytoid dendritic cells in HIV type 1 infection AIDS Research and Human Retroviruses 2010 26 2 161 171
76. Feldman S., Stein D., Amrute S., Denny T., Garcia Z., Kloser P., Sun Y., Megjugorac N., Fitzgerald-Bocarsly P., Decreased interferon- production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors Clinical Immunology 2001 101 2 201 210
77. Finke J. S., Shodell M., Shah K., Siegal F. P., Steinman R. M., Dendritic cell numbers in the blood of HIV-1 infected patients before and after changes in antiretroviral therapy Journal of Clinical Immunology 2004 24 6 647 652 (Pubitemid 40933116)
78. Siegal F. P., Fitzgerald-Bocarsly P., Holland B. K., Shodell M., Interferon- generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection AIDS 2001 15 13 1603 1612 (Pubitemid 32918114)
79. Sabado R. L., O'Brien M., Subedi A., Qin L., Hu N., Taylor E., Dibben O., Stacey A., Fellay J., Shianna K. V., Siegal F., Shodell M., Shah K., Larsson M., Lifson J., Nadas A., Marmor M., Hutt R., Margolis D., Garmon D., Markowitz M., Valentine F., Borrow P., Bhardwaj N., Evidence of dysregulation of dendritic cells in primary HIV infection Blood 2010 116 19 3839 3852
80. Martinson J. A., Tenorio A. R., Montoya C. J., Al-Harthi L., Gichinga C. N., Krieg A. M., Baum L. L., Landay A. L., Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals Immunology 2007 120 4 526 535 (Pubitemid 46365012)
81. Schmidt B., Fujimura S. H., Martin J. N., Levy J. A., Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy Journal of Clinical Immunology 2006 26 1 55 64 (Pubitemid 43112625)
82. Ratnam I., Chiu C., Kandala N. B., Easterbrook P. J., Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort Clinical Infectious Diseases 2006 42 3 418 427 (Pubitemid 43122323)
83. Lund J., Sato A., Akira S., Medzhitov R., Iwasaki A., Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells Journal of Experimental Medicine 2003 198 3 513 520 (Pubitemid 36976063)
84. Fox P. A., Nathan M., Francis N., Singh N., Weir J., Dixon G., Barton S. E., Bower M., A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod AIDS 2010 24 15 2331 2335
85. Ulmer A., Mller M., Bertisch-Mllenhoff B., Frietsch B., Low dose prednisolone reduces CD4+ T cell loss in therapy-naive HIV-patients without antiretroviral therapy European Journal of Medical Research 2005 10 3 105 109 (Pubitemid 40514878)
86. Ulmer A., Mller M., Bertisch-Mllenhoff B., Frietsch B., Low-dose prednisolone has a CD4-stabilizing effect in pre-treated HIV-patients during structured therapy interruptions (STI) European Journal of Medical Research 2005 10 6 227 232 (Pubitemid 40903988)
87. Gringeri A., Santagostino E., Cusini M., Mua-Perja M., Marinoni A., Mannucci P. M., Burny A., Criscuolo M., Lu W., Andrieru J. M., Mbika J. P., Lachgar A., Fall L. -S., Chams V., Feldman M., Hermans P., Zagury J. F., Bizzini B., Musicco M., Zagury D., Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon- immunization: a 30-month follow-up report Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1996 13 1 55 67
88. Gringeri A., Musicco M., Hermans P., Bentwich Z., Cusini M., Bergamasco A., Santagostino E., Burny A., Bizzini B., Zagury D., Active anti-interferon- immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1-infected patients (the EURIS study) Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1999 20 4 358 370 (Pubitemid 29143030)
89. Martinson J. A., Montoya C. J., Usuga X., Ronquillo R., Landay A. L., Desai S. N., Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation Antimicrobial Agents and Chemotherapy 2010 54 2 871 881
90. Hong Z., Jiang Z., Liangxi W., Guofu D., Ping L., Yongling L., Wendong P., Minghai W., Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release International Immunopharmacology 2004 4 2 223 234 (Pubitemid 38296351)
91. Murray S. M., Down C. M., Boulware D. R., Stauffer W. M., Cavert W. P., Schacker T. W., Brenchley J. M., Douek D. C., Reduction of immune activation with chloroquine therapy during chronic HIV infection Journal of Virology 2010 84 22 12082 12086
92. Piconi S., Parisotto S., Rizzardini G., Passerini S., Terzi R., Argenteri B., Meraviglia P., Capetti A., Biasin M., Trabattoni D., Clerici M., Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders Blood 2011 118 12 3263 3272
93. Aguirre-Cruz L., Torres K. J., Jung-Cook H., Fortuny C., Snchez E., Soda-Mehry A., Sotelo J., Reyes-Tern G., Short communication: preferential concentration of hydroxychloroquine in adenoid tissue of HIV-infected subjects AIDS Research and Human Retroviruses 2010 26 3 339 342